Peptidream Inc., of Kanagawa, Japan, said it inked a deal with Seattle-based Pharmain Corp. to investigate the use of the latter's drug carrier and delivery PGC (protected graft co-polymer) technology in combination with Peptidream's peptide discovery and development programs.